Intuitive Surgical (ISRG) experienced a 5.12% plummet during Friday's intraday trading session, underperforming the broader market as the company's slower procedure growth forecast for 2025 weighed on investor sentiment.
The medical technology company reported better-than-expected earnings and revenue for the fourth quarter, driven by strong sales of its da Vinci surgical robots. However, Intuitive Surgical's outlook for 2025 worldwide da Vinci procedure growth of 13% to 16% fell short of the 17% increase witnessed in the previous year, sparking concerns among investors.
Analysts noted that while the guidance was conservative, in line with Intuitive Surgical's typical approach, the slower projected growth rate compared to 2024 contributed to the stock's sell-off. Traders were skeptical about the company's ability to sustain its momentum, given the potential headwinds in certain market segments and the competitive landscape.